CSIMarket Company Name, Ticker, Industry, else..
 
Omega Therapeutics Inc   (NASDAQ: OMGA)
 

Omega Therapeutics Inc's Suppliers Performance

OMGA's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
OMGA Costs vs Sales of Suppliers Growth

• More on OMGA Suppliers






Omega Therapeutics Inc's Comment on Supply Chain


Regulatory requirements for raw materials, clinical trials, and non-clinical studies address contamination risks and ethical concerns related to gene-editing technologies. Approvals from regulatory authorities in foreign countries are required prior to conducting clinical trials or marketing products. Non-clinical studies must adhere to good laboratory practice (GLP) principles in accordance with EU Directive 2004/10/EC and OECD standards. Clinical trials conducted in the EU must comply with EU and national regulations, International Council for Harmonisation (ICH) guidelines on Good Clinical Practices (GCP), and ethical principles outlined in the Declaration of Helsinki. Additional GCP guidelines apply specifically to advanced therapy medicinal products (ATMPs). Sponsors located outside the EU are required to appoint an EU legal representative and provide clinical trial insurance and compensation for injuries. The EU Clinical Trials Regulation (CTR), effective January 31, 2022, harmonizes the assessment and supervision of clinical trials across EU member states through a centralized portal and database.

Omega Therapeutics Inc's Comment on Supply Chain


Regulatory requirements for raw materials, clinical trials, and non-clinical studies address contamination risks and ethical concerns related to gene-editing technologies. Approvals from regulatory authorities in foreign countries are required prior to conducting clinical trials or marketing products. Non-clinical studies must adhere to good laboratory practice (GLP) principles in accordance with EU Directive 2004/10/EC and OECD standards. Clinical trials conducted in the EU must comply with EU and national regulations, International Council for Harmonisation (ICH) guidelines on Good Clinical Practices (GCP), and ethical principles outlined in the Declaration of Helsinki. Additional GCP guidelines apply specifically to advanced therapy medicinal products (ATMPs). Sponsors located outside the EU are required to appoint an EU legal representative and provide clinical trial insurance and compensation for injuries. The EU Clinical Trials Regulation (CTR), effective January 31, 2022, harmonizes the assessment and supervision of clinical trials across EU member states through a centralized portal and database.







OMGA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Omega Therapeutics Inc 7.87 8.09 -73.09 63
SUBTOTAL 0.00 0.00 0.00 -


Sources: Omega Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Omega Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.